Identification of Clinically Significant Cytokine Signature Clusters in Patients With Septic Shock.
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
17
11
2023
pubmed:
8
9
2023
entrez:
7
9
2023
Statut:
ppublish
Résumé
To identify cytokine signature clusters in patients with septic shock. Prospective observational cohort study. Single academic center in the United States. Adult (≥ 18 yr old) patients admitted to the medical ICU with septic shock requiring vasoactive medication support. None. One hundred fourteen patients with septic shock completed cytokine measurement at time of enrollment (t 1 ) and 24 hours later (t 2 ). Unsupervised random forest analysis of the change in cytokines over time, defined as delta (t 2 -t 1 ), identified three clusters with distinct cytokine profiles. Patients in cluster 1 had the lowest initial levels of circulating cytokines that decreased over time. Patients in cluster 2 and cluster 3 had higher initial levels that decreased over time in cluster 2 and increased in cluster 3. Patients in clusters 2 and 3 had higher mortality compared with cluster 1 (clusters 1-3: 11% vs 31%; odds ratio [OR], 3.56 [1.10-14.23] vs 54% OR, 9.23 [2.89-37.22]). Cluster 3 was independently associated with in-hospital mortality (hazard ratio, 5.24; p = 0.005) in multivariable analysis. There were no significant differences in initial clinical severity scoring or steroid use between the clusters. Analysis of either t 1 or t 2 cytokine measurements alone or in combination did not reveal clusters with clear clinical significance. Longitudinal measurement of cytokine profiles at initiation of vasoactive medications and 24 hours later revealed three distinct cytokine signature clusters that correlated with clinical outcomes.
Identifiants
pubmed: 37678209
doi: 10.1097/CCM.0000000000006032
pii: 00003246-990000000-00203
doi:
Substances chimiques
Cytokines
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e253-e263Subventions
Organisme : NHLBI NIH HHS
ID : T32 HL007605
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002389
Pays : United States
Organisme : NIH HHS
ID : R03 HL148295
Pays : United States
Organisme : NIH HHS
ID : R03 HL148295
Pays : United States
Informations de copyright
Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Déclaration de conflit d'intérêts
Drs. Zhao, Patel, Stutz, Pearson, Adegunsoye, and Verhoef received support for article research from the National Institutes of Health (NIH). Dr. Patel’s institution received funding from the NIH (K23 HL148387); she received funding from The American College of Chest Physicians and Merck. Dr. Pearson received funding from the National Heart, Lung, and Blood Institute (NHLBI) (T32 HL 7605). Dr. Hall received funding from McGraw Hill Publishing. Drs. Hall and Adegunsoye received funding from the American College of Chest Physicians. Dr. Adegunsoye received funding from the Pulmonary Fibrosis Foundation and the NIH; he disclosed that he serves on a pulmonary fibrosis educational forum and advisory board for Boehringer Ingelheim, Inogen, and Roche. Dr. Verhoef’s institution received funding from the NHLBI. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Références
Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801–810
Nunnally ME, Ferrer R, Martin GS, et al.: The surviving sepsis campaign: Research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med Exp. 2021; 9:1–26
Torio C, Moore B: National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013. HCUP Statistical Brief #204. Rockville, MD, Agency for Healthcare Research and Quality, May2016, pp 1–15. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-MostExpensive-Hospital-Conditions.pdf . Accessed August 25, 2023
Paoli CJ, Reynolds MA, Sinha M, et al.: Epidemiology and costs of sepsis in the United States—an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018; 46:1889–1897
Rangel-Frausto MS, Pittet D, Costigan M, et al.: The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. JAMA. 1995; 273:117–123
Vincent J-L, De Mendonça A, Cantraine F, et al.: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med. 1998; 26:1793–1800
Knaus WA, Draper EA, Wagner DP, et al.: APACHE II: A severity of disease classification system. Crit Care Med. 1985; 13:818–829
Reinhart K, Bauer M, Riedemann NC, et al.: New approaches to sepsis: Molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25:609–634
Ding R, Meng Y, Ma X: The central role of the inflammatory response in understanding the heterogeneity of sepsis-3. Biomed Res Int. 2018; 2018:5086516
Coopersmith CM, De Backer D, Deutschman CS, et al.: Surviving sepsis campaign: Research priorities for sepsis and septic shock. Intensive Care Med. 2018; 44:1400–1426
Van Engelen TS, Wiersinga WJ, Scicluna BP, et al.: Biomarkers in sepsis. Crit Care Clin. 2018; 34:139–152
van der Poll T, van de Veerdonk FL, Scicluna BP, et al.: The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017; 17:407–420
Nguyen HB, Corbett SW, Steele R, et al.: Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007; 35:1105–1112
DeMerle KM, Angus DC, Baillie JK, et al.: Sepsis subclasses: A framework for development and interpretation. Crit Care Med. 2021; 49:748–759
Moore WC, Meyers DA, Wenzel SE, et al.; National Heart, Lung, and Blood Institute’s Severe Asthma Research Program: Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010; 181:315–323
Calfee CS, Delucchi K, Parsons PE, et al.; NHLBI ARDS Network: Latent class analysis of ARDS subphenotypes: Analysis of data from two randomized controlled trials. Lancet Respir Med. 2014; 2:611–620
Adegunsoye A, Oldham JM, Chung JH, et al.: Phenotypic clusters predict outcomes in a longitudinal interstitial lung disease cohort. Chest. 2018; 153:349–360
Pierrakos C, Vincent J-L: Sepsis biomarkers: A review. Crit care. 2010; 14:R15–R18
Larsen FF, Petersen JA: Novel biomarkers for sepsis: A narrative review. Eur J Intern Med. 2017; 45:46–50
Jekarl DW, Kim JY, Ha JH, et al.: Diagnosis and prognosis of sepsis based on use of cytokines, chemokines, and growth factors. Dis Markers. 2019; 2019:1089107
Knox DB, Lanspa MJ, Kuttler KG, et al.: Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med. 2015; 41:814–822
Churpek MM, Snyder A, Sokol S, et al.: Investigating the impact of different suspicion of infection criteria on the accuracy of qSOFA, SIRS, and early warning scores. Crit Care Med. 2017; 45:1805–1812
Shimabukuro DW, Barton CW, Feldman MD, et al.: Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: A randomised clinical trial. BMJ Open Respir Res. 2017; 4:e000234
Matsumoto H, Ogura H, Shimizu K, et al.: The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 2018; 8:13995
Razazi K, Boissier F, Surenaud M, et al.: A multiplex analysis of sepsis mediators during human septic shock: A preliminary study on myocardial depression and organ failures. Ann Intensive Care. 2019; 9:64
Eckart A, Hauser SI, Kutz A, et al.: Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: Results of a multinational, observational study. BMJ Open. 2019; 9:e024636
Remick DG, Bolgos G, Copeland S, et al.: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun. 2005; 73:2751–2757
Hotchkiss RS, Moldawer LL, Opal SM, et al.: Sepsis and septic shock. Nat Rev Dis Primers. 2016; 2:1–21
Harbarth S, Holeckova K, Froidevaux C, et al.; Geneva Sepsis Network: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164:396–402
Abasiyanik MF, Wolfe K, Van Phan H, et al.: Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes. Nat Commun. 2020; 11:2607
Fu Q, Schoenhoff FS, Savage WJ, et al.: Multiplex assays for biomarker research and clinical application: Translational science coming of age. Proteomics Clin Appl. 2010; 4:271–284
Tian Y, Yao Y, Zhou J, et al.: Dynamic APACHE II score to predict the outcome of intensive care unit patients. Front Med. 2022; 8:3139
Ferreira FL, Bota DP, Bross A, et al.: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001; 286:1754–1758
Belletti A, Lerose CC, Zangrillo A, et al.: Vasoactive-inotropic score: Evolution, clinical utility, and pitfalls. J Cardiothorac Vasc Anesth. 2021; 35:3067–3077
Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40:373–383
La D, Livesay DR: Predicting functional sites with an automated algorithm suitable for heterogeneous datasets. BMC Bioinf. 2005; 6:116
Kaufman L, Rousseeuw PJ: Finding Groups in Data: An Introduction to Cluster Analysis. Hoboken, NJ, John Wiley & Sons, 2009
Vitrano A, Musallam KM, Meloni A, et al.: Random forest clustering identifies three subgroups of β-thalassemia with distinct clinical severity. Thalassemia Rep. 2022; 12:14–23
Shi T, Horvath S: Unsupervised learning with random forest predictors. J Comput Graph Stat. 2006; 15:118–138
Alhusain L, Hafez AM: Cluster ensemble based on random forests for genetic data. BioData Mining. 2017; 10:37
Strobl C, Boulesteix A-L, Zeileis A, et al.: Bias in random forest variable importance measures: Illustrations, sources and a solution. BMC Bioinf. 2007; 8:25
Anderberg SB, Luther T, Berglund M, et al.: Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients. Cytokine. 2021; 138:155389
Kellum JA, Kong L, Fink MP, et al.; GenIMS Investigators: Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med. 2007; 167:1655–1663
Fajgenbaum DC, June CH: Cytokine storm. N Engl J Med. 2020; 383:2255–2273
Guo Y, Luan L, Patil NK, et al.: IL-15 enables septic shock by maintaining NK cell integrity and function. J Immunol. 2017; 198:1320–1333
Verhoef PA, Bhavani SV, Carey KA, et al.: Allergic immune diseases and the risk of mortality among patients hospitalized for acute infection. Crit Care Med. 2019; 47:1735–1742
Krishack PA, Louviere TJ, Decker TS, et al.: Protection against Staphylococcus aureus bacteremia–induced mortality depends on ILC2s and eosinophils. JCI Insight. 2019; 4:e124168
Denstaedt SJ, Singer BH, Standiford TJ: Sepsis and nosocomial infection: Patient characteristics, mechanisms, and modulation. Front Immunol. 2018; 9:2446
Delano MJ, Ward PA: Sepsis-induced immune dysfunction: Can immune therapies reduce mortality? J Clin Invest. 2016; 126:23–31
Venet F, Monneret G: Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018; 14:121–137